COPD Management & Pharmacotherapy: A GOLD Guideline Topline
Get GOLD Report updates at-a-glance on initiating pharmacotherapy, avoiding exacerbations, treating dyspnea, how to approach using ICS, plus other topics.
COPD Management: Smoking cessation, reduce risk for exacerbation, inhaled pharmacotherapy
COPD pharmacotherapy should be tailored to individual patients, guided by symptom severity, exacerbation risk, patient response/preferences
All COPD patients should be encouraged to stay current with immunizations and to participate in pulmonary rehabilitation programs
Oxygen therapy in COPD: Base patient selection on hypoxemia level and avoid routine prescription in resting or moderate exercise-induced desaturation
COPD oxygen therapy in chronic hypercapnia may help decrease mortality
Smoking cessation support for persons with COPD is essential for optimal prognosis
Initial COPD pharmacotherapy selection should be based on history and severity of exacerbation/s
Targeted treatment for dyspnea in COPD
Assess treatment intensity for COPD exacerbations based on blood eosinophil count
Treatment for COPD exacerbations if response to initial therapy is inadequate
When to consider inhaled corticosteroid therapy for individuals with COPD
Inhaler technique and adherence to therapy should be assessed
before concluding that the current therapy is insufficient
before concluding that the current therapy is insufficient
Observe COPD inhaler use carefully with specific focus on technique for dry powder and metered-dose inhalers
Pulmonary rehabilitation in COPD reaps considerable benefits and "has been shown shown to be the most effective therapeutic strategy to improve shortness of breath, health status and exercise tolerance.”
The 2024 Global Initiative for Obstructive Lung Disease (GOLD) report updates recommendations on management of chronic obstructive pulmonary disease (COPD) after the major revisions made to the recommendations in 2023.
In part 2 of our GOLD Report guideline topline slideshow, click through topline notes on these and other topics:
- Initiating pharmacotherapy
- Strategies if initial treatment is insufficient
- Avoiding, treating disease exacerbations
Optimizing inhaled treatment - ... More
